Nitric Oxide Synthase Type II
"Nitric Oxide Synthase Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.
| Descriptor ID |
D052247
|
| MeSH Number(s) |
D08.811.682.664.500.772.500 D12.776.157.687.575 D12.776.660.720.575
|
| Concept/Terms |
Nitric Oxide Synthase Type II- Nitric Oxide Synthase Type II
- Inducible NOS Protein
- NOS-II
- NOS II
- Nitric Oxide Synthase II
- Nitric Oxide Synthase, Type II
- Inducible Nitric Oxide Synthase
- INOS Enzyme
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Synthase Type II".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Synthase Type II".
This graph shows the total number of publications written about "Nitric Oxide Synthase Type II" by people in this website by year, and whether "Nitric Oxide Synthase Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 9 | 11 |
| 2018 | 4 | 13 | 17 |
| 2019 | 3 | 4 | 7 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitric Oxide Synthase Type II" by people in Profiles.
-
Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems. Nitric Oxide. 2021 06 01; 111-112:64-71.
-
Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids. Mediators Inflamm. 2021; 2021:6699560.
-
Novel insight from the first lung transplant of a COVID-19 patient. Eur J Clin Invest. 2021 Jan; 51(1):e13443.
-
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
-
Effect of Ergothioneine on 7-Ketocholesterol-Induced Endothelial Injury. Neuromolecular Med. 2021 03; 23(1):184-198.
-
Attenuation of acute and chronic inflammation using compounds derived from plants. Exp Biol Med (Maywood). 2021 02; 246(4):406-413.
-
Renal protective effects of aloin in a mouse model of sepsis. Food Chem Toxicol. 2019 Oct; 132:110651.
-
Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression. Life Sci. 2019 Sep 01; 232:116588.
-
iNOS Inhibition Reduces Lung Mechanical Alterations and Remodeling Induced by Particulate Matter in Mice. Pulm Med. 2019; 2019:4781528.
-
Agmatine ameliorates acetic acid-induced colitis in rats: involvement of nitrergic system. Immunopharmacol Immunotoxicol. 2019 Apr; 41(2):242-249.